{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:01:37Z","timestamp":1793246497296,"version":"4.5.0"},"reference-count":281,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003493","name":"Gemeinn\u00fctzige Hertie-Stiftung","doi-asserted-by":"publisher","award":["2021-1A-12"],"award-info":[{"award-number":["2021-1A-12"]}],"id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["EXC2151\\u2013390873048"],"award-info":[{"award-number":["EXC2151\\u2013390873048"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015621","name":"IFM Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative e V","doi-asserted-by":"publisher","award":["21060"],"award-info":[{"award-number":["21060"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.immuni.2024.03.010","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T10:42:18Z","timestamp":1712659338000},"page":"790-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Innate immune activation in neurodegenerative diseases"],"prefix":"10.1016","volume":"57","author":[{"given":"Sergio","family":"Castro-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4996-1630","authenticated-orcid":false,"given":"Michael T.","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2024.03.010_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","article-title":"Molecular pathology of neurodegenerative diseases: principles and practice","volume":"72","author":"Kovacs","year":"2019","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer's disease","volume":"19","author":"Trejo-Lopez","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.immuni.2024.03.010_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/neup.12812","article-title":"Neuropathology of alpha-synuclein in Parkinson's disease","volume":"42","author":"Choong","year":"2022","journal-title":"Neuropathology"},{"key":"10.1016\/j.immuni.2024.03.010_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jnc.13588","article-title":"Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies","volume":"138","author":"Mackenzie","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.immuni.2024.03.010_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/WCO.0000000000001098","article-title":"Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis","volume":"35","author":"Del Tredici","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","author":"R\u00fcb","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib11","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s12276-022-00895-w","article-title":"Inflammation promotes synucleinopathy propagation","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210542","article-title":"Activated microglia mitigate Abeta-associated tau seeding and spreading","volume":"218","author":"Gratuze","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"Kumar","year":"2011","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.14202\/vetworld.2018.627-635","article-title":"The crucial roles of inflammatory mediators in inflammation: a review","volume":"11","author":"Abdulkhaleq","year":"2018","journal-title":"Vet. World"},{"key":"10.1016\/j.immuni.2024.03.010_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.immuni.2024.03.010_bib19","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1007\/s12035-023-03289-9","article-title":"Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics","volume":"60","author":"Kaur","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","article-title":"Danger-associated molecular patterns in Alzheimer's disease","volume":"101","author":"Venegas","year":"2017","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.immuni.2024.03.010_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2014.01.001","article-title":"Pattern recognition receptors and central nervous system repair","volume":"258","author":"Kigerl","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib23","article-title":"Toll-Like Receptors: General Molecular and Structural Biology","volume":"2021","author":"Behzadi","year":"2021","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.immuni.2024.03.010_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13024-023-00672-x","article-title":"Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders","volume":"18","author":"Huang","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.immuni.2024.03.010_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13024-022-00583-3","article-title":"Glial interference: impact of type I interferon in neurodegenerative diseases","volume":"17","author":"Roy","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.immuni.2024.03.010_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","article-title":"Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience","volume":"26","author":"Udeochu","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-022-01118-0","article-title":"Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study","volume":"15","author":"Brosseron","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.immuni.2024.03.010_bib29","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","article-title":"Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview","volume":"50","author":"Brosseron","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.immuni.2024.03.010_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-804766-8.00009-1","article-title":"Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias","volume":"167","author":"Lopez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2024.03.010_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk9993","article-title":"Current status of amyloid-targeting immunotherapies for Alzheimer's disease","volume":"15","author":"Tabor","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00702-020-02232-9","article-title":"Neuropathological assessment of the Alzheimer spectrum","volume":"127","author":"Jellinger","year":"2020","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.immuni.2024.03.010_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib38","article-title":"Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants","volume":"13","author":"Hoogmartens","year":"2021","journal-title":"Alzheimers Dement. (Amst)"},{"key":"10.1016\/j.immuni.2024.03.010_bib39","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2003.12.015","article-title":"Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation","volume":"25","author":"Braak","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.immuni.2024.03.010_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","article-title":"The pathological process underlying Alzheimer's disease in individuals under thirty","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib44","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.03.010_bib45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","article-title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration","volume":"185","author":"Tracy","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168553","article-title":"Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues","volume":"133","author":"Samudra","year":"2023","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2024.03.010_bib48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00115-019-0778-3","article-title":"Neuroinflammation as motor of Alzheimer's disease","volume":"90","author":"Castro-Gomez","year":"2019","journal-title":"Nervenarzt"},{"key":"10.1016\/j.immuni.2024.03.010_bib49","first-page":"792","article-title":"An early and late peak in microglial activation in Alzheimer's disease trajectory","volume":"140","author":"Fan","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104511","article-title":"The complex genetic architecture of Alzheimer's disease: novel insights and future directions","volume":"90","author":"Andrews","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.immuni.2024.03.010_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101755","article-title":"Chronic inflammation and the hallmarks of aging","volume":"74","author":"Baechle","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.immuni.2024.03.010_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110521","article-title":"Immunosenescence as a convergence pathway in neurodegeneration","volume":"121","author":"Mohapatra","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.immuni.2024.03.010_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","article-title":"Traumatic Brain Injury and Risk of Neurodegenerative Disorder","volume":"91","author":"Brett","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib54","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/brain\/awab094","article-title":"Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease","volume":"144","author":"Asby","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib55","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3233\/JAD-200303","article-title":"Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review","volume":"76","author":"Muzambi","year":"2020","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/odi.14054","article-title":"Periodontal bacteria in the brain-Implication for Alzheimer's disease: A systematic review","volume":"29","author":"Parra-Torres","year":"2023","journal-title":"Oral Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib57","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jds.2022.07.001","article-title":"Association of periodontitis and oral microbiomes with Alzheimer's disease: A narrative systematic review","volume":"17","author":"Mao","year":"2022","journal-title":"J.\u00a0Dent. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib58","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/mp.2015.129","article-title":"Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation","volume":"21","author":"Chuang","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jalz.2017.06.2637","article-title":"Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study","volume":"14","author":"Singh-Manoux","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.immuni.2024.03.010_bib60","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer's disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.immuni.2024.03.010_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","article-title":"APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and\u00a0spread","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.03.010_bib63","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","article-title":"TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation","volume":"188","author":"Liu","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib64","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1172\/JCI96209","article-title":"Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology","volume":"128","author":"Rangasamy","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2024.03.010_bib65","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1523\/JNEUROSCI.1146-08.2008","article-title":"Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1\u201342 and delay the cognitive decline in a mouse model of Alzheimer's disease","volume":"28","author":"Richard","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib66","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.18632\/aging.102260","article-title":"Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer's disease","volume":"11","author":"Zhou","year":"2019","journal-title":"Aging (Albany, NY)"},{"key":"10.1016\/j.immuni.2024.03.010_bib67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","article-title":"CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils","volume":"160","author":"Coraci","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib68","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 mediates the innate host response to beta-amyloid","volume":"197","author":"El Khoury","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib69","doi-asserted-by":"crossref","first-page":"13415","DOI":"10.1074\/jbc.M117.784983","article-title":"Intramembrane attenuation of the TLR4-TLR6 dimer impairs receptor assembly and reduces microglia-mediated neurodegeneration","volume":"292","author":"Shmuel-Galia","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2024.03.010_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib71","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.181.1.503","article-title":"Dynamic protein associations define two phases of IL-1beta transcriptional activation","volume":"181","author":"Zhang","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib72","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.4049\/jimmunol.1700352","article-title":"Cutting Edge: Distinct Regulatory\u00a0Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1beta","volume":"198","author":"Zhu","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12414","article-title":"Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-kappaB\/GSDMD signal in mice adipose tissue","volume":"63","author":"Liu","year":"2017","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.immuni.2024.03.010_bib75","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS\u00a0signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.03.010_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-5-23","article-title":"Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease","volume":"5","author":"Jin","year":"2008","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-8-92","article-title":"TLR4 mutation reduces microglial activation, increases Abeta deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease","volume":"8","author":"Song","year":"2011","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib78","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/brain\/awl249","article-title":"Role of toll-like receptor signalling in Abeta uptake and clearance","volume":"129","author":"Tahara","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib79","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20180484","article-title":"TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease","volume":"215","author":"Chakrabarty","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4172\/Neuropsychiatry.1000243","article-title":"Tlr7 Deletion Selectively Ameliorates Spatial Learning but does not Influence beta Deposition and Inflammatory Response in an Alzheimers Disease Mouse Model","volume":"07","author":"Yu Liu","year":"2017","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nn.3113","article-title":"An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration","volume":"15","author":"Lehmann","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13024-021-00498-5","article-title":"MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7\/8 ligands that contribute to neurodegeneration","volume":"16","author":"Wallach","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.immuni.2024.03.010_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02166-0","article-title":"Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protection","author":"Cacace","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib84","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1523\/JNEUROSCI.5715-08.2009","article-title":"Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology","volume":"29","author":"Scholtzova","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib85","first-page":"101","article-title":"Amyloid beta and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation","volume":"2","author":"Scholtzova","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib86","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1523\/JNEUROSCI.1967-16.2016","article-title":"Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits","volume":"37","author":"Scholtzova","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib87","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-023-00849-x","article-title":"The NLR gene family: from discovery to present day","volume":"23","author":"Chou","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib88","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib89","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib90","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/cdd.2015.16","article-title":"Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation","volume":"22","author":"Kaushal","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.immuni.2024.03.010_bib91","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/ijms21031144","article-title":"Caspase-6 Knockout in the 5xFAD Model of Alzheimer's Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks","volume":"21","author":"Angel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib92","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41418-021-00881-1","article-title":"Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment","volume":"29","author":"Flores","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.immuni.2024.03.010_bib93","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib94","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jnc.14945","article-title":"Soluble Abeta oligomers and protofibrils induce NLRP3 inflammasome activation in microglia","volume":"155","author":"Lu\u010di\u016bnait\u0117","year":"2020","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.immuni.2024.03.010_bib95","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib96","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in\u00a0vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib97","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41380-022-01437-6","article-title":"Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation","volume":"27","author":"Neumann","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib98","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1074\/jbc.M116.769695","article-title":"NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding","volume":"292","author":"Eren","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2024.03.010_bib99","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-immunol-070119-115052","article-title":"Innate Immune Response to Cytoplasmic DNA: Mechanisms and Diseases","volume":"38","author":"Hu","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","article-title":"Activation of innate immune cGAS-STING pathway contributes to Alzheimer's pathogenesis in 5xFAD mice","volume":"3","author":"Xie","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib101","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-021-26851-2","article-title":"Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib102","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib103","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41586-020-2174-3","article-title":"AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment","volume":"580","author":"Lammert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000477092","article-title":"Deletion of the Inflammasome Sensor Aim2 Mitigates Abeta Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model","volume":"24","author":"Wu","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.immuni.2024.03.010_bib105","article-title":"Conditional knockout of AIM2 in microglia ameliorates synaptic plasticity and spatial memory deficits in a mouse model of Alzheimer's disease","author":"Ye","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.immuni.2024.03.010_bib106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 Receptor in Infection and Inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.03.010_bib107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","article-title":"New role of P2X7 receptor in an Alzheimer's disease mouse model","volume":"24","author":"Martin","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102139","article-title":"P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy","volume":"206","author":"Carvalho","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib109","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.20171487","article-title":"P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model","volume":"215","author":"Reichenbach","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib110","article-title":"P2Y1R silencing in Astrocytes Protected Neuroinflammation and Cognitive Decline in a Mouse Model of Alzheimer's Disease","author":"Luo","year":"2023","journal-title":"Aging Dis"},{"key":"10.1016\/j.immuni.2024.03.010_bib111","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00702-008-0067-y","article-title":"Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology","volume":"115","author":"Lai","year":"2008","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.immuni.2024.03.010_bib112","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12035-013-8577-5","article-title":"Loss of P2Y(2) nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease","volume":"49","author":"Ajit","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib113","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-215611","article-title":"Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease","volume":"87","author":"Jian","year":"2022","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110148","article-title":"The microglial P2Y(6) receptor mediates neuronal loss and memory deficits in neurodegeneration","volume":"37","author":"Puigdell\u00edvol","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151201","article-title":"G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau(RD)-mediated by membrane-associated actin cytoskeleton remodeling in microglia","volume":"101","author":"Chidambaram","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.immuni.2024.03.010_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105684","article-title":"Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease","volume":"167","author":"Kenkhuis","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib117","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab011","article-title":"Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor","volume":"3","author":"Maeda","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib118","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","article-title":"TREM2 drives microglia response to amyloid-beta via SYK-dependent and -independent pathways","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib119","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.immuni.2024.03.010_bib121","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.immuni.2024.03.010_bib122","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib123","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib124","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2021.12.016","article-title":"Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease","volume":"110","author":"Brosseron","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.immuni.2024.03.010_bib126","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00401-023-02564-2","article-title":"TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia","volume":"145","author":"Winfree","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib127","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib128","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022113246","article-title":"Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models","volume":"42","author":"Rueda-Carrasco","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2024.03.010_bib129","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.03.010_bib130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-023-01160-z","article-title":"TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation","volume":"15","author":"Moutinho","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib131","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/glia.24318","article-title":"Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss","volume":"71","author":"Popescu","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.immuni.2024.03.010_bib132","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuron.2022.10.022","article-title":"TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4","volume":"111","author":"Gratuze","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.immuni.2024.03.010_bib133","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib141","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib142","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1189\/jlb.1012519","article-title":"RAGE regulation and signaling in inflammation and beyond","volume":"94","author":"Kierdorf","year":"2013","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.immuni.2024.03.010_bib143","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.immuni.2024.03.010_bib135","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/sj.emboj.7600415","article-title":"RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice","volume":"23","author":"Arancio","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2024.03.010_bib136","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.09-139634","article-title":"RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning\/memory in a mouse model of Alzheimer's disease","volume":"24","author":"Fang","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.immuni.2024.03.010_bib137","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/hmg\/ddy017","article-title":"RAGE mediates Abeta accumulation in a mouse model of Alzheimer's disease via modulation of beta- and gamma-secretase activity","volume":"27","author":"Fang","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.immuni.2024.03.010_bib144","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and\u00a0accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib145","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib146","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.03.010_bib147","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","article-title":"The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Abeta Plaques","volume":"27","author":"Sala Frigerio","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib138","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.7150\/ijbs.81900","article-title":"beta-amyloid binds to microglia Dectin-1 to induce inflammatory response in the pathogenesis of Alzheimer's disease","volume":"19","author":"Zhao","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib148","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","article-title":"SYK coordinates neuroprotective microglial responses in neurodegenerative disease","volume":"185","author":"Ennerfelt","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib149","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.immuni.2024.03.010_bib150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.2010.06637.x","article-title":"Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1\u201342-induced signal transduction in glial cells","volume":"113","author":"Brandenburg","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.immuni.2024.03.010_bib151","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/molecules22030455","article-title":"The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition","volume":"22","author":"He","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.immuni.2024.03.010_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102642","article-title":"Amyloid beta and its naturally occurring N-terminal variants are potent activators of human and mouse formyl peptide receptor 1","volume":"298","author":"Busch","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2024.03.010_bib152","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41467-022-29361-x","article-title":"Structural basis of FPR2 in recognition of Abeta(42) and neuroprotection by humanin","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib153","doi-asserted-by":"crossref","first-page":"23645","DOI":"10.1074\/jbc.M101031200","article-title":"Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain","volume":"276","author":"Tiffany","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2024.03.010_bib139","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-020-01816-2","article-title":"Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease","volume":"17","author":"Schr\u00f6der","year":"2020","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib154","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of alpha-synuclein and its relationship to Parkinson\u2019s disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.immuni.2024.03.010_bib156","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib157","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","article-title":"Genomic investigation of alpha-synuclein multiplication and parkinsonism","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib158","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in\u00a0vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib159","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41380-021-01296-7","article-title":"Brain regions susceptible to alpha-synuclein spreading","volume":"27","author":"Guo","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib161","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib162","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00702-020-02271-2","article-title":"Iron and inflammation: in\u00a0vivo and post-mortem studies in Parkinson's disease","volume":"128","author":"Martin-Bastida","year":"2021","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.immuni.2024.03.010_bib163","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2019.07.018","article-title":"Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study","volume":"16","author":"Brosseron","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.immuni.2024.03.010_bib164","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib165","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.3233\/JPD-223245","article-title":"Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies","volume":"12","author":"Terkelsen","year":"2022","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib166","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.immuni.2024.03.010_bib167","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct alpha-Synuclein Assemblies","volume":"207","author":"Scheiblich","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib168","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib169","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-kappaB pathway reduces alpha-synuclein spreading in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Dutta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbi.2018.12.003","article-title":"TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in\u00a0vivo model","volume":"76","author":"Campolo","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.immuni.2024.03.010_bib171","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","article-title":"P2X7 receptor is critical in alpha-synuclein--mediated microglial NADPH oxidase activation","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib172","first-page":"E1926","article-title":"alpha-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.03.010_bib173","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.redox.2017.11.010","article-title":"Integrin CD11b mediates alpha-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.immuni.2024.03.010_bib174","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.4049\/jimmunol.1900494","article-title":"Size-Selective Phagocytic Clearance of Fibrillar alpha-Synuclein through Conformational Activation of Complement Receptor 4","volume":"204","author":"Juul-Madsen","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111401","article-title":"Interaction of RAGE with alpha-synuclein fibrils mediates inflammatory response of microglia","volume":"40","author":"Long","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib176","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded alpha-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib177","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib178","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma alpha-synuclein levels are correlated with motor severity\u00a0and progression in Parkinson's disease","volume":"17","author":"Fan","year":"2020","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib179","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/toxsci\/kfx117","article-title":"Editor's Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice","volume":"159","author":"Martinez","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577543","article-title":"A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease","volume":"354","author":"Huang","year":"2021","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib182","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","article-title":"Inflammasome inhibition protects dopaminergic neurons from alpha-synuclein pathology in a model of progressive Parkinson's disease","volume":"20","author":"Grotemeyer","year":"2023","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib183","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81943","article-title":"Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice","volume":"11","author":"Szego","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2024.03.010_bib184","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118819119","article-title":"STING mediates neurodegeneration and neuroinflammation in nigrostriatal alpha-synucleinopathy","volume":"119","author":"Hinkle","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.03.010_bib185","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","article-title":"The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson's disease via LCN2-dependent astrocyte senescence","volume":"30","author":"Jiang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.immuni.2024.03.010_bib186","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib187","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","article-title":"Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes","volume":"184","author":"Scheiblich","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib188","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate alpha-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib189","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","article-title":"Microglia as modulators of exosomal alpha-synuclein transmission","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib190","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/brain\/awab122","article-title":"Reactive microglia enhance the transmission of exosomal alpha-synuclein via toll-like receptor 2","volume":"144","author":"Xia","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib191","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T\u00a0cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib192","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.immuni.2024.03.010_bib193","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2024.03.010_bib194","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.immuni.2024.03.010_bib195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2021.02.017","article-title":"Abnormal subpopulations of monocytes in the cerebrospinal fluid of patients with Parkinson's disease","volume":"84","author":"Pillny","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.immuni.2024.03.010_bib196","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson's disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib197","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2022.01.005","article-title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition","volume":"101","author":"Konstantin Nissen","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.immuni.2024.03.010_bib198","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/ijms24010264","article-title":"Peripheral Inflammatory Markers TNF-alpha and CCL2 Revisited: Association with Parkinson's Disease Severity","volume":"24","author":"Xiromerisiou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib199","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","article-title":"LRRK2 levels in immune cells are increased in Parkinson's disease","volume":"3","author":"Cook","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","article-title":"Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease","volume":"300","author":"Harms","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib201","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib202","first-page":"691","article-title":"Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue","volume":"140","author":"Kawamata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib204","first-page":"249","article-title":"Effect of an exercise program on the perception of exertion in males at retirement","volume":"15","author":"Wong","year":"1990","journal-title":"Can. J. Sport Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","article-title":"Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue","volume":"179","author":"Casula","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.immuni.2024.03.010_bib206","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/acn3.51112","article-title":"11 C-PK11195 PET-based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis","volume":"7","author":"Tondo","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib207","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12974-018-1135-3","article-title":"Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients","volume":"15","author":"Perner","year":"2018","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib208","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1523\/JNEUROSCI.4786-03.2004","article-title":"Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis","volume":"24","author":"Nguyen","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib209","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj0264","article-title":"Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS","volume":"14","author":"Hop","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib210","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.03.010_bib211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib212","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.1002396107","article-title":"Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis","volume":"107","author":"Meissner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.03.010_bib213","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","article-title":"TDP-43 activates microglia through NF-kappaB and NLRP3 inflammasome","volume":"273","author":"Zhao","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib214","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.immuni.2024.03.010_bib215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/glia.20919","article-title":"Extracellular mutant SOD1 induces microglial-mediated motoneuron injury","volume":"58","author":"Zhao","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.immuni.2024.03.010_bib216","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12974-015-0310-z","article-title":"Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Lee","year":"2015","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib217","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.phrs.2015.11.020","article-title":"Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model","volume":"103","author":"De Paola","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.immuni.2024.03.010_bib218","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/ijms18081666","article-title":"Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model","volume":"18","author":"Fellner","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib219","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s12035-020-02019-9","article-title":"Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis","volume":"57","author":"Lee","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-022-02466-9","article-title":"Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex","volume":"144","author":"Van Schoor","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib221","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105859","article-title":"Functional and structural consequences of TBK1 missense variants in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"174","author":"Gurfinkel","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib223","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2021.01.015","article-title":"Deletion of the inflammatory S100-A9\/MRP14 protein does not influence survival in hSOD1(G93A) ALS mice","volume":"101","author":"Ribon","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib224","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12974-019-1435-2","article-title":"Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"16","author":"Lee","year":"2019","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib225","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41418-018-0098-3","article-title":"Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes","volume":"25","author":"Komine","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.immuni.2024.03.010_bib226","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/07853890.2012.665471","article-title":"The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum","volume":"44","author":"Van Langenhove","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib227","doi-asserted-by":"crossref","first-page":"11732","DOI":"10.3390\/ijms241411732","article-title":"Frontotemporal Dementia, Where Do We Stand? A Narrative Review","volume":"24","author":"Antonioni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2024.03.010_bib228","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","article-title":"Frontotemporal dementia and its subtypes: a genome-wide association study","volume":"13","author":"Ferrari","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib229","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ana.20332","article-title":"In\u00a0vivo detection of microglial activation in frontotemporal dementia","volume":"56","author":"Cagnin","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib230","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/brain\/awaa033","article-title":"Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum","volume":"143","author":"Bevan-Jones","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib231","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp-2020-323698","article-title":"In\u00a0vivo PET imaging of neuroinflammation in familial frontotemporal dementia","volume":"92","author":"Malpetti","year":"2021","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib232","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/brain\/awad078","article-title":"Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia","volume":"146","author":"Malpetti","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.immuni.2024.03.010_bib233","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/acn3.50875","article-title":"Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations","volume":"6","author":"Sakae","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib234","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00401-007-0230-9","article-title":"Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation","volume":"114","author":"Miklossy","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib235","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e318200d78d","article-title":"Novel CSF biomarkers for frontotemporal lobar degenerations","volume":"75","author":"Hu","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.immuni.2024.03.010_bib236","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2015.05.006","article-title":"Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers","volume":"49","author":"Galimberti","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.immuni.2024.03.010_bib237","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neurobiolaging.2017.09.032","article-title":"Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia","volume":"62","author":"Pawlowski","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib238","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-021-02247-3","article-title":"Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation","volume":"18","author":"Sogorb-Esteve","year":"2021","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2024.03.010_bib239","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.mp.4001508","article-title":"Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy","volume":"9","author":"G\u00f6tz","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.immuni.2024.03.010_bib240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-981-32-9358-8_28","article-title":"Experimental Models of Tauopathy - From Mechanisms to Therapies","volume":"1184","author":"G\u00f6tz","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.immuni.2024.03.010_bib241","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib242","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41419-017-0153-x","article-title":"Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration","volume":"9","author":"Ising","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109720","article-title":"Proteopathic tau primes and activates interleukin-1beta via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway","volume":"36","author":"Jiang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib244","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/cne.22430","article-title":"Progranulin expression in the developing and adult murine brain","volume":"518","author":"Petkau","year":"2010","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12035-012-8380-8","article-title":"Mechanisms of granulin deficiency: lessons from cellular and animal models","volume":"47","author":"Kleinberger","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib246","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ajpath.2010.11.002","article-title":"Progranulin is a chemoattractant for microglia and stimulates their endocytic activity","volume":"178","author":"Pickford","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib247","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib248","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/13554794.2018.1506039","article-title":"Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia","volume":"24","author":"Woollacott","year":"2018","journal-title":"Neurocase"},{"key":"10.1016\/j.immuni.2024.03.010_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109581","article-title":"Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD","volume":"36","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","article-title":"Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice","volume":"207","author":"Yin","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib251","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.03.010_bib252","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-020-01037-x","article-title":"Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations","volume":"8","author":"Huang","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.immuni.2024.03.010_bib253","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/alz.13536","article-title":"Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity","volume":"20","author":"Borrego-\u00c9cija","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.immuni.2024.03.010_bib254","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O'Rourke","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.03.010_bib255","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fnins.2019.01298","article-title":"Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","volume":"13","author":"Trageser","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib256","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/antiox12101896","article-title":"Glycine-Alanine Dipeptide Repeat Protein from C9-ALS Interacts with Sulfide Quinone Oxidoreductase (SQOR) to Induce the Activity of the NLRP3 Inflammasome in HMC3 Microglia: Irisflorentin Reverses This Interaction","volume":"12","author":"Fu","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.immuni.2024.03.010_bib257","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1007\/s12035-023-03315-w","article-title":"Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia\/Amyotrophic Lateral Sclerosis","volume":"60","author":"Trageser","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib258","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","article-title":"C9orf72 in myeloid cells suppresses STING-induced inflammation","volume":"585","author":"McCauley","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib259","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4699","article-title":"Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss","volume":"13","author":"Rodriguez","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.03.010_bib260","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.15252\/embj.201488740","article-title":"TDP-1, the Caenorhabditis elegans ortholog of TDP-43, limits the accumulation of double-stranded RNA","volume":"33","author":"Saldi","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2024.03.010_bib261","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bcp.2007.07.043","article-title":"The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities","volume":"75","author":"Unterholzner","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.immuni.2024.03.010_bib262","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00401-020-02176-0","article-title":"Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS","volume":"140","author":"LaClair","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.immuni.2024.03.010_bib263","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.immuni.2024.03.010_bib264","doi-asserted-by":"crossref","first-page":"2077.e11","DOI":"10.1016\/j.neurobiolaging.2013.02.016","article-title":"Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease","volume":"34","author":"Giraldo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib265","doi-asserted-by":"crossref","first-page":"444.e1","DOI":"10.1016\/j.neurobiolaging.2013.08.011","article-title":"Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer\u2019s disease and frontotemporal dementia","volume":"35","author":"Ruiz","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib266","doi-asserted-by":"crossref","first-page":"726.e11","DOI":"10.1016\/j.neurobiolaging.2013.09.009","article-title":"Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia","volume":"35","author":"Cuyvers","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib267","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.immuni.2024.03.010_bib268","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.neurobiolaging.2015.08.019","article-title":"Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.immuni.2024.03.010_bib269","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.15252\/embj.201796516","article-title":"The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism","volume":"36","author":"Kleinberger","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2024.03.010_bib270","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.stemcr.2018.03.003","article-title":"Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia","volume":"10","author":"Brownjohn","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112133","article-title":"Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome","volume":"42","author":"Shu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2024.03.010_bib272","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1088124","article-title":"Neuroinflammation in Huntington's disease: from animal models to clinical therapeutics","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.03.010_bib273","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1172\/JCI90605","article-title":"Microglia in prion diseases","volume":"127","author":"Aguzzi","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2024.03.010_bib274","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-022-05474-7","article-title":"Brain borders at the central stage of neuroimmunology","volume":"612","author":"Rustenhoven","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib275","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T\u00a0cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib276","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.abf7266","article-title":"CD4(+) T\u00a0cells contribute to neurodegeneration in Lewy body dementia","volume":"374","author":"Gate","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.03.010_bib277","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.03.010_bib278","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41593-023-01323-6","article-title":"The contribution of the peripheral immune system to neurodegeneration","volume":"26","author":"Berriat","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.immuni.2024.03.010_bib279","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106461","article-title":"T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease","volume":"193","author":"Zeng","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.immuni.2024.03.010_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101971","article-title":"Microglial innate memory and epigenetic reprogramming in neurological disorders","volume":"200","author":"Martins-Ferreira","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.immuni.2024.03.010_bib281","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","article-title":"Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.immuni.2024.03.010_bib134","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.biopsych.2017.10.007","article-title":"Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging","volume":"83","author":"Condello","year":"2018","journal-title":"Biol. Psychiatry"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324001316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324001316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:22:32Z","timestamp":1762363352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761324001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":281,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1074761324001316"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2024.03.010","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate immune activation in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2024.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}